Aprea Therapeutics, Inc. Interest Income (Expense), Nonoperating, Net
Aprea Therapeutics, Inc. (APRE) reported Interest Income (Expense), Nonoperating, Net of $358.92 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-08-12
- Aprea Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was $358.92K, a 101.61% increase year-over-year.
- Aprea Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was $134.78K, a 34.16% decline year-over-year.
- Aprea Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was $118.66K, a 56.79% decline year-over-year.
- Aprea Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was $150.67K, a 56.80% decline year-over-year.
- Aprea Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2025 was $652.09K, a 49.42% decline from fiscal 2024.
- Aprea Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2024 was $1.29M, a 5.31% increase from fiscal 2023.
- Aprea Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2023 was $1.22M, a 172.84% increase from fiscal 2022.
- Aprea Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2022 was $448.67K, a 27124.94% increase from fiscal 2021.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $358.92K 10-Q · filed 2026-08-12 | $493.71K 10-Q · filed 2026-08-12 | $612.37K derived: sum of 3 quarters · filed 2026-08-12 | $763.04K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $134.78K 10-Q · filed 2026-05-13 | $253.45K derived: sum of 2 quarters · filed 2026-05-13 | $404.12K derived: sum of 3 quarters · filed 2026-05-13 | $582.14K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $118.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $269.33K derived: sum of 2 quarters · filed 2026-03-16 | $447.36K derived: sum of 3 quarters · filed 2026-08-12 | $652.09K 10-K · filed 2026-03-16 |
| 2025-09-30 | $150.67K 10-Q · filed 2025-11-12 | $328.70K derived: sum of 2 quarters · filed 2026-08-12 | $533.42K 10-Q · filed 2025-11-12 | $808.05K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $178.03K 10-Q · filed 2026-08-12 | $382.75K 10-Q · filed 2026-08-12 | $657.38K derived: sum of 3 quarters · filed 2026-08-12 | $1.01M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $204.73K 10-Q · filed 2026-05-13 | $479.35K derived: sum of 2 quarters · filed 2026-05-13 | $828.09K derived: sum of 3 quarters · filed 2026-05-13 | $1.21M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $274.63K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $623.37K derived: sum of 2 quarters · filed 2026-03-16 | $1.01M derived: sum of 3 quarters · filed 2026-03-16 | $1.29M 10-K · filed 2026-03-16 |
| 2024-09-30 | $348.74K 10-Q · filed 2025-11-12 | $731.12K derived: sum of 2 quarters · filed 2025-11-12 | $1.01M 10-Q · filed 2025-11-12 | $1.32M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $382.37K 10-Q · filed 2025-08-12 | $665.78K 10-Q · filed 2025-08-12 | $976.06K derived: sum of 3 quarters · filed 2025-08-12 | $1.30M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $283.40K 10-Q · filed 2025-05-14 | $593.69K derived: sum of 2 quarters · filed 2025-05-14 | $914.90K derived: sum of 3 quarters · filed 2025-05-14 | $1.25M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $310.29K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $631.50K derived: sum of 2 quarters · filed 2025-03-25 | $967.72K derived: sum of 3 quarters · filed 2025-03-25 | $1.22M 10-K · filed 2025-03-25 |
| 2023-09-30 | $321.21K 10-Q · filed 2024-11-07 | $657.44K derived: sum of 2 quarters · filed 2024-11-07 | $913.85K 10-Q · filed 2024-11-07 | $1.16M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $336.22K 10-Q · filed 2024-08-12 | $592.63K 10-Q · filed 2024-08-12 | $835.71K derived: sum of 3 quarters · filed 2024-08-12 | $986.84K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $256.41K 10-Q · filed 2024-05-14 | $499.49K derived: sum of 2 quarters · filed 2024-05-14 | $650.62K derived: sum of 3 quarters · filed 2024-05-14 | $703.11K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $243.08K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $394.20K derived: sum of 2 quarters · filed 2024-03-26 | $446.70K derived: sum of 3 quarters · filed 2024-03-26 | $448.67K 10-K · filed 2024-03-26 |
| 2022-09-30 | $151.12K 10-Q · filed 2023-11-09 | $203.61K derived: sum of 2 quarters · filed 2023-11-09 | $205.59K 10-Q · filed 2023-11-09 | $208.91K derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-06-30 | $52.49K 10-Q · filed 2023-08-10 | $54.46K 10-Q · filed 2023-08-10 | $57.79K derived: sum of 3 quarters · filed 2024-03-26 | $57.76K derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-03-31 | $1.97K 10-Q · filed 2023-05-15 | $5.30K derived: sum of 2 quarters · filed 2024-03-26 | $5.26K derived: sum of 3 quarters · filed 2024-03-26 | $4.68K derived: sum of 4 quarters · filed 2024-03-26 |
| 2021-12-31 | $3.33K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $3.29K derived: sum of 2 quarters · filed 2024-03-26 | $2.71K derived: sum of 3 quarters · filed 2024-03-26 | $1.65K 10-K · filed 2024-03-26 |
| 2021-09-30 | -$33.00 10-Q · filed 2022-11-09 | -$621.00 derived: sum of 2 quarters · filed 2022-11-09 | -$1.68K 10-Q · filed 2022-11-09 | $3.07K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-06-30 | -$588.00 10-Q · filed 2022-08-12 | -$1.65K 10-Q · filed 2022-08-12 | $3.10K derived: sum of 3 quarters · filed 2023-03-30 | -$6.11K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-03-31 | -$1.06K 10-Q · filed 2022-05-16 | $3.69K derived: sum of 2 quarters · filed 2023-03-30 | -$5.53K derived: sum of 3 quarters · filed 2023-03-30 | -$2.85K derived: sum of 4 quarters · filed 2023-03-30 |
| 2020-12-31 | $4.74K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$4.47K derived: sum of 2 quarters · filed 2023-03-30 | -$1.79K derived: sum of 3 quarters · filed 2023-03-30 | $222.65K 10-K · filed 2023-03-30 |
| 2020-09-30 | -$9.21K 10-Q · filed 2021-11-08 | -$6.53K derived: sum of 2 quarters · filed 2021-11-08 | $217.91K 10-Q · filed 2021-11-08 | $387.80K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $2.68K 10-Q · filed 2021-08-12 | $227.12K 10-Q · filed 2021-08-12 | $397.01K derived: sum of 3 quarters · filed 2022-03-15 | $390.91K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $224.44K 10-Q · filed 2021-05-06 | $394.33K derived: sum of 2 quarters · filed 2022-03-15 | $388.23K derived: sum of 3 quarters · filed 2022-03-15 | $384.14K derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $169.89K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $163.79K derived: sum of 2 quarters · filed 2022-03-15 | $159.70K derived: sum of 3 quarters · filed 2022-03-15 | $156.35K 10-K · filed 2022-03-15 |
| 2019-09-30 | -$6.10K 10-Q · filed 2020-11-06 | -$10.19K derived: sum of 2 quarters · filed 2020-11-06 | -$13.54K 10-Q · filed 2020-11-06 | -$13.54K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | -$4.09K 10-Q · filed 2020-08-11 | -$7.44K 10-Q · filed 2020-08-11 | -$7.44K derived: sum of 3 quarters · filed 2021-03-16 | -$7.43K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | -$3.35K 10-Q · filed 2020-05-15 | -$3.35K derived: sum of 2 quarters · filed 2021-03-16 | -$3.34K derived: sum of 3 quarters · filed 2021-03-16 | |
| 2018-12-31 | $2.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $6.00 derived: sum of 2 quarters · filed 2021-03-16 | -$182.00 10-K · filed 2021-03-16 | |
| 2018-09-30 | $4.00 10-Q · filed 2019-11-14 | -$184.00 10-Q · filed 2019-11-14 | ||
| 2017-12-31 | -$15.00 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |